Dan Turner

6PUBLICATIONS
49CO-AUTHORS
Infant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Upadacitinib treatment in pediatric Crohn's disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN.

|Aug 20, 2026
Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|Mar 17, 2026
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.

Elisabeth De Greef, Dan Turner, Jarosław Kierkuś

|Jan 08, 2026
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.

Dan Turner, Kathleen G Lomax, Gigi Veereman

Pageof 1

Frequent Collaborators

3 joint publications

Anne M Griffiths

2 joint publications

Marco Gasparetto

2 joint publications

Kaija-Leena Kolho

2 joint publications

Iva Hojsak